Clinical Trial Update: Metronomic Chemotherapy in Elderly Non-fit Patients With Aggressive B-Cell Lymphomas [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating metronomic chemotherapy in elderly, non-fit patients with aggressive B-cell lymphomas has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aggressive Non-hodgkin Lymphoma

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: Aggressive Non-Hodgkin Lymphoma | Phase 2 | Status: COMPLETED